Insys Therapeutics Inc (INSY) - Product Pipeline Analysis, 2018 Update

Insys Therapeutics Inc (Insys) is a specialty pharmaceutical company, which discovers, develops and commercializes novel drug delivery systems of therapeutic compounds. The company harnesses its proprietary sublingual spray technology to develop pharmaceutical cannabinoids. Its flagship product, Subsys, is a sublingual fentanyl spray for breakthrough cancer pain (BTCP). Its lead product candidate, Syndros (dronabinol oral solution), is intended for the treatment of chemotherapy-induced nausea and vomiting (CINV) and anorexia associated with weight loss in AIDS patients. The company offers its products to oncologists, pain specialists and supportive care centers for the potential treatment of addiction to opioids, opioid overdose and epilepsy. It has operations in the US and offers its products in international markets. Insys is headquartered in Chandler, Arizona, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Insys Therapeutics Inc

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to buy

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Insys Therapeutics Inc Company Overview

Insys Therapeutics Inc Company Snapshot

Insys Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview

Insys Therapeutics Inc - Pipeline Analysis Overview

Business Description

Insys Therapeutics Inc - Key Facts

Insys Therapeutics Inc - Major Products and Services

Insys Therapeutics Inc Pipeline Products by Development Stage

Insys Therapeutics Inc Pipeline Products Overview

Buprenorphine Sublingual Spray Device

Buprenorphine Sublingual Spray Device Product Overview

Buprenorphine/Naloxone Sublingual Spray

Buprenorphine/Naloxone Sublingual Spray Product Overview

Naloxone Sublingual Spray

Naloxone Sublingual Spray Product Overview

Ondansetron Sublingual Spray

Ondansetron Sublingual Spray Product Overview

Insys Therapeutics Inc - Key Competitors

Insys Therapeutics Inc - Key Employees

Insys Therapeutics Inc - Key Employee Biographies

Insys Therapeutics Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

Insys Therapeutics Inc, Recent Developments

Apr 02, 2018: INSYS Therapeutics Appoints Trudy Vanhove to Board of Directors

Mar 08, 2018: INSYS Therapeutics Reports Fourth Quarter and Full Year 2017 Results

Feb 09, 2018: INSYS Therapeutics Addresses Maryland Attorney General’s Motion

Feb 01, 2018: INSYS Therapeutics Appoints Vaseem Mahboob to Board of Directors

Jan 30, 2018: INSYS Therapeutics Announces Senior Management Changes

Dec 06, 2017: FDA Accepts New Drug Application (NDA) for Buprenorphine Sublingual Spray from INSYS Therapeutics

Nov 02, 2017: INSYS Therapeutics Reports Third Quarter 2017 Results

Oct 29, 2017: INSYS Therapeutics Founder Dr. John N. Kapoor Steps Down from Board of Directors

Oct 29, 2017: INSYS Therapeutics Announces Resignation of Patrick P. Fourteau from Board of Directors

Oct 06, 2017: INSYS Therapeutics Addresses New Jersey Complaint

Appendix

Methodology

About

Contact

Disclaimer

List of Tables

Insys Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview

Insys Therapeutics Inc Pipeline Products by Equipment Type

Insys Therapeutics Inc Pipeline Products by Indication

Insys Therapeutics Inc, Key Facts

Insys Therapeutics Inc, Major Products and Services

Insys Therapeutics Inc Number of Pipeline Products by Development Stage

Insys Therapeutics Inc Pipeline Products Summary by Development Stage

Buprenorphine Sublingual Spray Device - Product Status

Buprenorphine Sublingual Spray Device - Product Description

Buprenorphine/Naloxone Sublingual Spray - Product Status

Buprenorphine/Naloxone Sublingual Spray - Product Description

Naloxone Sublingual Spray - Product Status

Naloxone Sublingual Spray - Product Description

Ondansetron Sublingual Spray - Product Status

Ondansetron Sublingual Spray - Product Description

Insys Therapeutics Inc, Key Employees

Insys Therapeutics Inc, Key Employee Biographies

Insys Therapeutics Inc, Other Locations

Insys Therapeutics Inc, Subsidiaries

Glossary

List of Figures

Insys Therapeutics Inc Pipeline Products by Equipment Type

Insys Therapeutics Inc Pipeline Products by Development Stage

Companies Mentioned

A selection of companies mentioned in this report includes:

Teva Pharmaceutical Industries Ltd
SELLAS Life Sciences Group Inc
Par Pharmaceutical Holdings Inc
Mallinckrodt, LLC
Depomed Inc
BioDelivery Sciences International Inc

Table of Contents

Companies Mentioned

Related Topics